Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine plus vitamin E versus vitamin E plus placebo for mastalgia in fibrocystic breast disease
IRCT20200205046381N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluoxetine and vitamin e in mastalgia and Mastopathy (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Pain. Started Mar 2020; status: completed.
02
Drugs
fluoxetinevitamin e
03
Conditions
mastalgiaMastopathy
Beyond the preview
Go deeper on IRCT20200205046381N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200205046381N1.